WebTreatment of MM.1S with the triple combination also induced an early increase in p53 (Figure 4B and Online Supplementary Figure S1A), an indicator of DNA damage response. This effect was more evident than that induced by zalypsis and bortezomib on their own ( Figure 4B ), and similar to that induced by the combination ZaB ( Figure 4B ). WebApr 9, 2024 · The effect of ΔNp63α expression on bortezomib-induced ROS levels showed that high expressions of ΔNp63α caused bortezomib to induce relatively fewer ROS, while low expressions of ΔNp63α did ...
Bortezomib Induces Anti-Multiple Myeloma Immune Response …
WebSep 1, 2024 · Bortezomib induced type-1 interferon responses by an increase in cytosolic DNA in the form of micronuclei, accumulation of the cytosolic DNA sensor cyclic GMP-AMP synthase (cGAS), activation of transmembrane protein 173 (TMEM173, best known as STING), and activating phosphorylation of TANK-binding kinase 1 (TBK1; ref. 1). WebJun 9, 2024 · DCZ3301 induced M phase cell cycle arrest in MM mainly via inhibiting DNA repair and enhancing DNA damage. Moreover, DCZ3301 promoted the phosphorylation of ATM, ATR, and their downstream proteins, and these responses were blocked by the ATM specific inhibitor KU55933. local richmond banks
Bortezomib-induced “BRCAness” sensitizes multiple …
WebSep 1, 2008 · Current knowledge of the mechanism underlying BIPN is very limited. 5 Mitochondrial and endoplasmic reticulum damage seems to play a key role in BIPN genesis, since bortezomib is able to activate the mitochondrial-based apoptotic pathway. 6 It has recently been reported that cotreatment with a panel of Ca ++-modulating agents … WebSep 27, 2024 · Multiple myeloma (MM) is a malignancy of terminally differentiated plasma cells, and accounts for 10% of all hematologic malignancies and 1% of all cancers. MM is characterized by genomic instability which results from DNA damage with certain genomic rearrangements being prognostic factors for the disease and patients’ clinical response. … WebNov 5, 2024 · Here we demonstrate that proteasome inhibitor bortezomib (BTZ) modulates the immunosuppressive bone marrow milieu by inducing immunogenic cell death (ICD) and a type-I interferon (IFN) response which contribute to its clinical efficacy. ... co-culture with BTZ-treated MM cells induced functional maturation of dendritic cells (DCs) and … indian geography for nda